Daiichi submits edoxaban MAA

Daiichi Sankyo Co. Ltd. (Tokyo:4568) submitted an MAA to EMA for edoxaban, an oral Factor Xa inhibitor. The pharma is seeking approval of the product to prevent stroke and systemic embolic events in p...